Department of Internal Medicine 3- Rheumatology & Immunology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Deutsches Zentrum Immuntherapie, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
JMIR Form Res. 2024 Sep 19;8:e57185. doi: 10.2196/57185.
Axial spondyloarthritis (AS) is a chronic inflammatory rheumatic disease characterized by potentially disabling inflammation of the spine and adjacent joints. Regular exercise is a cornerstone of treatment. However, patients with AS currently have little support. YogiTherapy (MaD Lab) is an app developed to support patients with AS by providing instructions for yoga-based home exercise therapy.
This study aimed to evaluate the usability and acceptance of the newly designed YogiTherapy app for patients with AS.
Patients completed the User Version of the Mobile Application Rating Scale (uMARS) and net promoter score (NPS) questionnaires after the app introduction. Wilcoxon Mann-Whitney rank sum test, chi-square test for count data, and correlation analysis were conducted to examine the usability of the app, acceptance, and patient characteristics.
A total of 65 patients with AS (33, 51% female; age: mean 43.3, SD 13.6 years) were included in the study from May 2022 to June 2023. Subsequently, the data were analyzed. Usability was rated moderate, with a mean uMARS of 3.35 (SD 0.47) points on a scale from 0 to 5. The highest-rated uMARS dimension was information (mean 3.88, SD 0.63), followed by functionality (mean 3.84, SD 0.87). Females reported a significantly higher uMARS total score than males (mean 3.47, SD 0.48 vs mean 3.23, SD 0.45; P=.03, Vargha and Delaney A [VDA] 0.66, 95% CI 0.53-0.77). The mean average of the NPS was 6.23 (SD 2.64) points (on a scale from 0 to 10), based on 43% (26/65 nonpromoters, 42% (25/65) indifferent, and 15% (9/65) promoters. A total of 7% (5/65) of those surveyed did not answer the question. When applying the NPS formula, the result is -26%. The NPS showed a positive correlation with the usage of mobile apps (r=0.39; P=.02). uMARS functionality was significantly higher rated by patients younger than 41 years (mean 4.17, SD 0.55 vs mean 3.54, SD 1; P<.001; VDA 0.69, 95% CI 0.56-0.80). Patients considering mobile apps as useful reported higher uMARS (r=0.38, P=.02). The uMARS app quality mean score was correlated with the frequency of using apps (r=-0.21, P<.001).
The results revealed moderate acceptance and usability ratings, prompting further app improvement. Significant differences were observed between age and gender. Our results emphasize the need for further improvements in YogiTherapy.
强直性脊柱炎(AS)是一种慢性炎症性风湿性疾病,其特征是脊柱和相邻关节可能出现致残性炎症。定期运动是治疗的基石。然而,目前 AS 患者几乎得不到任何支持。YogiTherapy(MaD Lab)是一款应用程序,旨在通过提供基于瑜伽的家庭运动疗法指导来支持 AS 患者。
本研究旨在评估新设计的 AS 患者使用的 YogiTherapy 应用程序的可用性和接受度。
在应用程序介绍后,患者完成了移动应用程序用户版本评估量表(uMARS)和净推荐值(NPS)问卷。采用 Wilcoxon 曼-惠特尼秩和检验、卡方检验(计数数据)和相关分析来检验应用程序的可用性、接受度和患者特征。
2022 年 5 月至 2023 年 6 月期间,共纳入了 65 名 AS 患者(33 名,51%为女性;年龄:平均 43.3,SD 13.6 岁)。随后对数据进行了分析。可用性评分为中等,uMARS 平均得分为 3.35(SD 0.47),分值范围为 0 至 5。评分最高的 uMARS 维度是信息(平均 3.88,SD 0.63),其次是功能(平均 3.84,SD 0.87)。女性报告的 uMARS 总分明显高于男性(平均 3.47,SD 0.48 比平均 3.23,SD 0.45;P=.03,Varga 和 Delaney A [VDA]0.66,95%CI0.53-0.77)。基于 42%(25/65)的患者为中立,42%(25/65)的患者为不确定,15%(9/65)的患者为推荐,NPS 的平均分数为 6.23(SD 2.64)(NPS 的分值范围为 0 至 10)。共有 7%(5/65)的受访者未回答该问题。应用 NPS 公式后,结果为-26%。NPS 与移动应用程序的使用呈正相关(r=0.39;P=.02)。年龄小于 41 岁的患者对 uMARS 功能的评分明显更高(平均 4.17,SD 0.55 比平均 3.54,SD 1;P<.001;VDA0.69,95%CI0.56-0.80)。认为移动应用程序有用的患者报告了更高的 uMARS(r=0.38,P=.02)。uMARS 应用程序质量的平均评分与应用程序使用频率呈负相关(r=-0.21,P<.001)。
研究结果显示出中等程度的接受度和可用性评分,提示需要进一步改进应用程序。年龄和性别之间存在显著差异。我们的研究结果强调了需要进一步改进 YogiTherapy。